Article

PPARγ is a tumor suppressor in basal bladder tumors offering new potential therapeutic…

medRxiv · 2019 · Coutos-Thevenot, L.; Beji, S.; Neyret-Kahn, H.; Pippo, Q.; Fontugne, J.; Osz, J.; Krucker, C.; Dos Santos Groeneveld, C.; Dufour, F.; Kamoun, A.; Ley, M.; Chapeaublanc, E.; De Reynies, A.; Lebret, T.; Allory, Y.; Cianferani, S.; Radvanyi, F.; Rochel, N.; BERNARD-PIERROT, I.

Key facts

Title PPARγ is a tumor suppressor in basal bladder tumors offering new potential therapeutic opportunities
First author Coutos-Thevenot, L.; Beji, S.; Neyret-Kahn, H.; Pippo, Q.; Fontugne, J.; Osz, J.; Krucker, C.; Dos Santos Groeneveld, C.; Dufour, F.; Kamoun, A.; Ley, M.; Chapeaublanc, E.; De Reynies, A.; Lebret, T.; Allory, Y.; Cianferani, S.; Radvanyi, F.; Rochel, N.; BERNARD-PIERROT, I.
Journal medRxiv
Published Dec 9, 2019
DOI 10.1101/868190
Product codes mentioned JJH, NQF, NSU, PFX

At a glance

  • None FDA submissions mentioned
  • 1–9 Product codes mentioned

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About Literature

Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.

Source: Publisher and PubMed metadata; device mentions identified by Orca1

Browse all Literature